Share on StockTwits

Novadaq Technologies (NASDAQ:NVDQ)‘s stock had its “underperform” rating reaffirmed by analysts at Northland Securities in a research report issued to clients and investors on Tuesday.

Novadaq Technologies (NASDAQ:NVDQ) traded down 3.66% during mid-day trading on Tuesday, hitting $14.75. 1,625,505 shares of the company’s stock traded hands. Novadaq Technologies has a 52 week low of $12.26 and a 52 week high of $24.09. The stock’s 50-day moving average is $16.31 and its 200-day moving average is $17.92. The company’s market cap is $814.0 million.

Novadaq Technologies (NASDAQ:NVDQ) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.18. The company had revenue of $11.20 million for the quarter, compared to the consensus estimate of $11.33 million. During the same quarter in the previous year, the company posted ($0.05) earnings per share. The company’s revenue for the quarter was up 38.3% on a year-over-year basis. Analysts expect that Novadaq Technologies will post $-0.25 EPS for the current fiscal year.

Separately, analysts at RBC Capital upgraded shares of Novadaq Technologies from a “sector perform” rating to an “outperform” rating in a research note on Thursday, May 8th. They now have a $18.00 price target on the stock. One investment analyst has rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating to the stock. Novadaq Technologies currently has a consensus rating of “Buy” and a consensus price target of $16.93.

Novadaq Technologies Inc develops and commercializes medical imaging and therapeutic devices for use in the operating room.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.